Windtree Therapeutics (WINT) Misses Q1 EPS by 12c

Windtree Therapeutics (NASDAQ: WINT) reported Q1 EPS of ($1.70), $0.12 worse than the analyst estimate of ($1.58). Revenue for the quarter came in at $75 thousand, versus $191 thousand reported last year.

For earnings history and earnings-related data on Windtree Therapeutics (WINT) click here.

You May Also Be Interested In

• NVIDIA stock gains as SemiAnalysis sees H2 data center revenue 20% above consensus
• Oppenheimer turns cautious on major U.S. banks, favors alternative asset managers
• Halozyme names David Ramsay as president of drug delivery